Key result
Treatment with colchicine and high-dose ibuprofen successfully resolved symptoms and reduced inflammatory markers in a 25-year-old woman with recurrent acute pericarditis secondary to COVID-19.
Case Report (n=1)
No
Dual therapy with colchicine and high-dose ibuprofen was effective in managing recurrent acute pericarditis secondary to COVID-19 infection.
Hypothesis-generating for colchicine plus ibuprofen in post-COVID pericarditis; larger prospective studies needed before clinical adoption.
The Coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiac injuries are among the complications caused by COVID-19. This report presents the case of a 25-year-old patient hospitalized due to Coronavirus infection with the complication of recurrent acute pericarditis. The patient was treated with colchicine and high-dose ibuprofen, and the patient was then discharged in stable condition. This report demonstrates an effective treatment plan for acute pericarditis secondary to COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2021) conducted a case report in Acute pericarditis secondary to COVID-19 infection (n=1). Colchicine and ibuprofen was evaluated on Clinical improvement and reduction in inflammatory markers. Treatment with colchicine and high-dose ibuprofen successfully resolved symptoms and reduced inflammatory markers in a 25-year-old woman with recurrent acute pericarditis secondary to COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: